Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00089245
Title Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Y-mAbs Therapeutics
Indications

medulloblastoma

Ewing sarcoma

rhabdoid cancer

neuroblastoma

Advanced Solid Tumor

Therapies

Omburtamab I-131

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.